Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 177

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 1
Chunk 177
---
 calendar years. In addition, non-employee directors will also be
reimbursed for out-of-pocket costs incurred in connection with attending meetings.

81

Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

PRINCIPAL
STOCKHOLDERS

The
following table sets forth, as of the date of this Annual Report, the beneficial ownership of our common stock by each director and executive
officer, by each person known by us to beneficially own 5% or more of our common stock and by directors and executive officers as a group.
Unless otherwise stated, the address of the persons set forth in the table is c/o Shuttle Pharmaceuticals Holdings, Inc., 401 Professional
Drive, Suite 260, Gaithersburg, MD 20879.

Beneficial
ownership is determined in accordance with SEC rules and generally includes voting or investment power with respect to securities. Unless
otherwise indicated, the stockholders listed in the table below have sole voting and investment power with respect to the shares indicated.

All
share ownership figures include shares of our commons stock issuable upon securities convertible or exchangeable into shares of our common
stock, whether or not convertible or exchangeable within 60 days of the effective date of this Annual Report. Such shares are deemed
outstanding and beneficially owned by such person only for purposes of computing his or her percentage ownership, but not for purposes
of computing the percentage ownership for any other person.

As
of February 24, 2025, there were issued and outstanding 4,076,567 shares of common stock.

    Names and addresses 
    Number of shares of common stock beneficially owned (#)  
    Percentage of shares of common stock beneficially owned (%) 
  
    Directors and Named Executive Officers: 

    Anatoly Dritschilo, M.D.(1) 
     639,083  
     15.7%
  
    Timothy Lorber(2) 
     -  
     - 
  
    Milton Brown, M.D., Ph.D. (3) 
     137,869  
     3.4%
  
    Mira Jung, Ph.D. (4)  
     135,715  
     3.3%
  
    Michael Vander Hoek 
     12,982  
     - 
  
    Peter Dritschilo 
     820  
     - 
  
    Tyvin A. Rich,